1.
J Law Med Ethics
; 50(S1): 8-23, 2022.
Artículo
en Inglés
| MEDLINE
| ID: mdl-35902089
RESUMEN
The U.S. has the tools to end the HIV epidemic, but progress has stagnated. A major gap in U.S. efforts to address HIV is the under-utilization of medications that can virtually eliminate acquisition of the virus, known as pre-exposure prophylaxis (PrEP). This document proposes a financing and delivery system to unlock broad access to PrEP for those most vulnerable to HIV acquisition and bring an end to the HIV epidemic.